Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05357404 · ClinicalTrials.gov registry record
Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE
A clinical trial of Valvular Heart Disease, sponsored by Cardiovascular Research Foundation, New York.
- Active
- Registry status
- 2,870
- Enrollment target
- 1
- Study location
NCT05357404 is a study of Valvular Heart Disease that is active but no longer recruiting, run by Cardiovascular Research Foundation, New York. The registered enrollment target is 2,870 participants, above the 823-participant average among 8 other Valvular Heart Disease trials with a reported enrollment target (249% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05357404, a study of Valvular Heart Disease, is active but no longer recruiting, sponsored by Cardiovascular Research Foundation, New York.
- ACTIVE NOT RECRUITING
- Registry status
- 2,870 participants
- Enrollment target
- 1
- Study location
Study Summary
The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).
Conditions Studied
Study Locations (1)
California
- Hawthorne Effect - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,870 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2025-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05357404
The ClinicalTrials.gov registry entry for NCT05357404 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,870 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 823-participant average among 8 other Valvular Heart Disease trials with a reported enrollment target (249% higher). The listed sponsor is Cardiovascular Research Foundation, New York, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Valvular Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05357404 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05357404 about?
NCT05357404 is a clinical study titled "Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE". The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).
What is the current status of trial NCT05357404?
This trial is currently active not recruiting. The enrollment target is 2,870 participants. The study started on 2022-04-21. Estimated completion is 2025-04.
What conditions does trial NCT05357404 study?
This clinical trial studies the following conditions: Valvular Heart Disease.
Who is sponsoring clinical trial NCT05357404?
This trial is sponsored by Cardiovascular Research Foundation, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05357404 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Valvular Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
RECRUITING · NA
-
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
RECRUITING
-
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm
RECRUITING
-
Abbott Structural Heart Device Registry
RECRUITING
-
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.